Stifel Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$520K Sell
7,153
-3,315
-32% -$255K ﹤0.01% 2961
2026
Q2
$867K Sell
10,468
-303
-3% -$24.3K ﹤0.01% 2646
2026
Q1
$828K Buy
10,771
+48
+0.4% +$3.75K ﹤0.01% 2563
2025
Q4
$846K Buy
10,723
+1,762
+20% +$153K ﹤0.01% 2548
2025
Q3
$821K Sell
8,961
-177
-2% -$14.4K ﹤0.01% 2517
2025
Q2
$596K Sell
9,138
-145
-2% -$9.44K ﹤0.01% 2667
2025
Q1
$622K Buy
9,283
+859
+10% +$51.3K ﹤0.01% 2543
2024
Q4
$466K Buy
8,424
+1,425
+20% +$81.8K ﹤0.01% 2718
2024
Q3
$418K Buy
+6,999
New +$427K ﹤0.01% 2783
2020
Q1
– Sell
-3,245
Closed -$201K – 2820
2019
Q4
$201K Buy
3,245
+450
+16% +$29.8K ﹤0.01% 2770
2019
Q3
$203K Sell
2,795
-126
-4% -$9.43K ﹤0.01% 2650
2019
Q2
$242K Sell
2,921
-114
-4% -$8.11K ﹤0.01% 2614
2019
Q1
$214K Buy
+3,035
New +$179K ﹤0.01% 2553
2018
Q4
– Sell
-3,847
Closed -$217K – 2664
2018
Q3
$217K Buy
3,847
+17
+0.4% +$1.04K ﹤0.01% 2540
2018
Q2
$256K Buy
3,830
+164
+4% +$10.2K ﹤0.01% 2395
2018
Q1
$215K Buy
+3,666
New +$233K ﹤0.01% 2436
2017
Q4
– Sell
-6,703
Closed -$349K – 2650
2017
Q3
$349K Buy
+6,703
New +$320K ﹤0.01% 2087

Other funds holding ANIP

Stifel Financial's ANIP Position: Q3 2026 in Review

Stifel Financial reduced its ANI Pharmaceuticals (ANIP) stake by 32% in Q3 2026, selling an estimated $255K and leaving 7,153 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #2961.

Stifel Financial first reported a position in ANIP in Q3 2017 and has held it in 17 quarters since. The position peaked at $867K in Q2 2026. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Stifel Financial held 7,153 shares of ANI Pharmaceuticals worth $520K as of Q3 2026.
  • Stifel Financial sold 3,315 ANI Pharmaceuticals shares in Q3 2026, an estimated $255K.
  • ANI Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #2961 holding.
  • Stifel Financial first reported a position in ANI Pharmaceuticals in Q3 2017 and has held it in 17 quarters since.
  • Stifel Financial's ANI Pharmaceuticals position peaked at $867K in Q2 2026.
  • 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.